Skip to content

Prolonging hepatitis C therapy by an additional 20 weeks has few benefits

Tenofovir provides an effective long-term treatment for hepatitis B in HIV-positive patients

No single drug associated with cryptogenic liver disease

Abacavir associated with a poorer response to HCV therapy

Only 25% of HIV-positive patients with acute HCV accepting HCV therapy

Two-thirds of HIV-positive gay men with acute HCV achieve a good response to HCV therapy

Low CD4 cell count, high HIV viral load are associated with occult HBV in HIV-positive patients

South African AIDS orphans and carers have greater depression, poorer health, need financial help

Voluntary counselling and testing: no effect on HIV incidence in rural Zimbabwe